Does South Carolina or Texas have more federal spending?

Texas leads stacked USAspending.gov obligations $72.7B to South Carolina’s $3.9B, spending per capita $686.1 to $83.98, awards 530,634 to 129,440, and FY2026 obligations $21.5B to $460.1M. Population is 5,478,831 in South Carolina and 31,290,831 in Texas.

What industries lead in South Carolina and Texas?

South Carolina’s top industry is biological product (except diagnostic) manufacturing. Texas’s is pharmaceutical preparation manufacturing. Those labels are the largest NAICS slices on $3.9B and $72.7B. Award counts are 129,440 in South Carolina and 530,634 in Texas.

Are South Carolina and Texas both life-sciences peaks?

South Carolina’s peak is biological product (except diagnostic) manufacturing. Texas’s peak is pharmaceutical preparation manufacturing. Both sit in a life-sciences orbit on $3.9B and $72.7B. They are not the same NAICS label. These figures are USAspending.gov obligations, not outlays.

Are South Carolina vs Texas figures Treasury outlays?

No. The $3.9B and $72.7B totals, and FY2026 amounts of $460.1M and $21.5B, are USAspending.gov obligations. Outlays are cash payments and can lag. Spending per capita ($83.98 vs $686.1) uses Census population where present. This packet does not publish outlays or average award size.

← All guides

South Carolina vs Texas on USAspending: $3.9B vs $72.7B

Texas’s stacked USAspending.gov obligation stock is $72.7B; South Carolina’s is $3.9B. Both peaks sit in a life-sciences orbit: pharmaceutical preparation manufacturing in Texas and biological product (except diagnostic) manufacturing in South Carolina. Population is 5,478,831 versus 31,290,831, and spending per capita is $83.98 versus $686.1. Award volume is 129,440 in South Carolina and 530,634 in Texas. FY2026 is $460.1M versus $21.5B. The figures are obligations, not outlays.

Key figures

Texas $72.7B vs South Carolina $3.9B in stacked USAspending obligations.
Per capita $686.1 vs $83.98 on 31,290,831 vs 5,478,831 residents.
Awards 530,634 vs 129,440; FY2026 $21.5B vs $460.1M.
Top industries: biological product manufacturing in South Carolina; pharmaceutical preparation manufacturing in Texas.
Figures are USAspending.gov obligations, not Treasury outlays.

Two life-sciences peaks on unmatched stocks

Texas’s $72.7B stacked stock sits well above South Carolina’s $3.9B. Census population leans Texas: 31,290,831 versus 5,478,831. Intensity follows. $686.1 per capita versus $83.98 is a wide gap. Cite those packet ratios beside the Census counts; they are not a second copy of $72.7B and $3.9B.

Award volume follows Texas, 530,634 versus 129,440. Row count is not average award size. Cite USAspending.gov. Do not invent a mean from 530,634 or 129,440.

Biological products versus pharmaceutical preparation

South Carolina’s lead NAICS is biological product (except diagnostic) manufacturing. Texas’s is pharmaceutical preparation manufacturing. A biologics peak is a first read on South Carolina’s $3.9B mix. A drug-manufacturing peak is a first read on Texas’s $72.7B mix. Both sit in a life-sciences orbit; they are not the same label.

The 129,440 South Carolina awards and 530,634 Texas awards include many actions outside those two industries. Use the South Carolina and Texas state hubs for agencies and recipients. Both peaks are USAspending.gov obligation mixes. Outlays are not in the packet.

South Carolina’s 129,440 awards and $460.1M FY2026 slice sit on 5,478,831 residents. Texas’s 530,634 awards and $21.5B sit on 31,290,831. Biological product (except diagnostic) manufacturing versus pharmaceutical preparation manufacturing remains a life-sciences contrast on $3.9B and $72.7B, not a matched label. $83.98 versus $686.1 is the intensity ranking. Cite USAspending.gov.

FY2026: South Carolina’s $460.1M versus Texas’s $21.5B

Fiscal year 2026 obligations are $460.1M in South Carolina and $21.5B in Texas. Recency preserves Texas’s stacked dollar lead. Treat the year as a recency slice of obligations, not as Treasury cash already paid.

Do not divide $460.1M or $21.5B by 129,440 or 530,634 all-years awards. Spending per capita of $83.98 and $686.1 already sits beside Census counts of 5,478,831 and 31,290,831. Cite USAspending.gov for both cuts.

What $83.98 looks like on 5,478,831 residents

South Carolina’s $3.9B on 5,478,831 people produces $83.98 per capita, much cooler than Texas’s $686.1 on 31,290,831. The biologics peak sits on that cooler ratio and on 129,440 awards. The $460.1M FY2026 slice is the recency cut on the smaller stock.

Texas’s pharmaceutical peak, 530,634 awards, and $21.5B latest-year amount remain the larger file. Read two life-sciences labels as a shared theme on unmatched stocks. Keep every dollar figure labeled as a USAspending.gov obligation.

How to read South Carolina versus Texas

Read Texas first on stacked dollars ($72.7B vs $3.9B), population (31,290,831 vs 5,478,831), awards (530,634 vs 129,440), spending per capita ($686.1 vs $83.98), and FY2026 ($21.5B vs $460.1M). Note biological product (except diagnostic) manufacturing versus pharmaceutical preparation manufacturing.

The comparison hub holds the tables. The South Carolina and Texas hubs hold agencies and recipients. Outlays are a different series. Cite USAspending.gov. Keep $83.98 and $686.1 labeled as Census-based obligation ratios.

Biologics and pharmaceuticals on unmatched stocks

South Carolina’s biological product (except diagnostic) manufacturing peak and Texas’s pharmaceutical preparation manufacturing peak both sit in a life-sciences orbit. They are not the same NAICS label. South Carolina’s $3.9B, 5,478,831 residents, 129,440 awards, $83.98 per capita, and $460.1M FY2026 slice remain the smaller file. Texas’s $72.7B, 31,290,831 residents, 530,634 awards, $686.1, and $21.5B remain the larger file.

Cite USAspending.gov. A shared life-sciences theme is not a matched mix. Outlays are not in the packet. Use the comparison hub for tables. Use the South Carolina and Texas hubs for agencies and recipients. Keep $83.98 and $686.1 labeled as Census-based obligation ratios.

Questions

Does South Carolina or Texas have more federal spending?: Texas leads stacked USAspending.gov obligations $72.7B to South Carolina’s $3.9B, spending per capita $686.1 to $83.98, awards 530,634 to 129,440, and FY2026 obligations $21.5B to $460.1M. Population is 5,478,831 in South Carolina and 31,290,831 in Texas.
What industries lead in South Carolina and Texas?: South Carolina’s top industry is biological product (except diagnostic) manufacturing. Texas’s is pharmaceutical preparation manufacturing. Those labels are the largest NAICS slices on $3.9B and $72.7B. Award counts are 129,440 in South Carolina and 530,634 in Texas.
Are South Carolina and Texas both life-sciences peaks?: South Carolina’s peak is biological product (except diagnostic) manufacturing. Texas’s peak is pharmaceutical preparation manufacturing. Both sit in a life-sciences orbit on $3.9B and $72.7B. They are not the same NAICS label. These figures are USAspending.gov obligations, not outlays.
Are South Carolina vs Texas figures Treasury outlays?: No. The $3.9B and $72.7B totals, and FY2026 amounts of $460.1M and $21.5B, are USAspending.gov obligations. Outlays are cash payments and can lag. Spending per capita ($83.98 vs $686.1) uses Census population where present. This packet does not publish outlays or average award size.

State comparison from SpendingVault aggregates of USAspending obligations. Per-capita uses Census population where present.